KEY FINDING The Asia-Pacific IBS-c drug market is predicted to grow at a CAGR of 8.85% over the forecast period of 2017-2025 and generate an estimated revenue of $875 million by the end of 2025. The high unmet needs for the drugs in the Asian region leading to a subsequent higher demand from the market are expected to boost the market growth in the coming years
MARKET INSIGHTS IBS being a heritable condition in some of the population, the poor and unhealthy eating habits and the pipeline drugs in the market are some of the major drivers for the Asian IBS-c drug market. The market is segmented according to the prescription type and drug type. The prescription type is further classified into over the counter drugs and prescription drugs, with the over the counter drugs being more in demand from the market. The drug type segment contains Stimulant Laxatives, Osmotic Laxatives, Lubiprostone, Linaclotide, and some pipeline drugs such as plecanatide. Of these, lubiprostone currently has the highest market share in the market. However, the change in lifestyle and the use of alternate natural ways to cure IBS might prove challenging for the market in the future.
COMPETITIVE INSIGHTS Prometheus Laboratories Inc, Norgine B.V, Actavis Nordic A/S, Yuhan Corp, Albireo Pharma Inc, AstraZeneca Plc, The Menarini Group and Ono Pharmaceutical Co Ltd are few of the established companies in the market.
Our reports have been used by over 10K customers, including:
218 pages •
By Transparency Market Research
• Sep 2017
Global Constipation Treatment Market: Scope and Methodology This report on the global constipation treatment market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The...
According to Stratistics MRC, the Global Psyllium Seed market is expected to grow from $XX million in 2016 to reach $XX million by 2022 with a CAGR of XX%. Health advantages in reducing heart diseases, constipation, and diarrhea are some of the factors propelling the market growth. Growing demand for psyllium seed in reducing obesity, inflammatory...
The Global Saline Laxative Market is poised to grow at a CAGR of around XX% over the next decade to reach approximately $XX million by 2025. Some of the prominent trends that the market is witnessing include occurrence of serious health issues with excessive usage of saline laxative, growing incidence of gastrointestinal diseases, recent technological...